Moramarco Antonio, di Geronimo Natalie, Zimbru Marian Sergiu, Grendele Arianna, Biagini Francesco, Mete Maurizio, Romano Vito, Fontana Luigi
Ophthalmology Unit, Dipartimento di Scienze Mediche e Chirurgiche, Alma Mater Studiorum University of Bologna, 40126 Bologna, Italy.
IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
J Clin Med. 2025 Aug 7;14(15):5568. doi: 10.3390/jcm14155568.
: Mushroom penetrating keratoplasty (MPK) is an alternative to traditional penetrating keratoplasty (PK) that offers improved graft survival and reduced immunological rejection. However, MPK grafts may still experience endothelial failure over time. This study evaluates the outcomes of non-Descemet Stripping Automated Endothelial Keratoplasty (nDSAEK) as a surgical approach for endothelial decompensation following MPK. : A monocentric, retrospective study was conducted at the Ophthalmology Department of Sant'Orsola-Malpighi Hospital, including patients who underwent nDSAEK for endothelial failure after MPK between 2022 and 2024. Pre- and postoperative best-corrected visual acuity (BCVA), central corneal thickness (CCT), and endothelial cell density (ECD) were assessed. : Eighteen eyes from 18 patients (mean age: 39.94 years) were included. Primary MPK indications were post-keratitis leucoma (77.7%), traumatic scarring (16.7%), and keratoconus (5.6%). At one year, mean BCVA improved significantly from 1.40 ± 0.42 logMAR to 0.46 ± 0.19 logMAR ( < 0.05), and mean CCT decreased from 721 ± 70.12 µm to 616 ± 52.80 µm ( < 0.05). The mean postoperative ECD was 1748 ± 100 cells/mm, with lower eye values requiring re-bubbling. No immunological rejection or graft failures were reported. : nDSAEK is a promising treatment for MPK endothelial failure, demonstrating good visual and anatomical outcomes.
蘑菇状穿透性角膜移植术(MPK)是传统穿透性角膜移植术(PK)的一种替代方法,可提高移植物存活率并减少免疫排斥反应。然而,随着时间的推移,MPK移植物仍可能出现内皮功能衰竭。本研究评估了非剥离Descemet膜的自动内皮角膜移植术(nDSAEK)作为MPK术后内皮失代偿的手术方法的效果。:在圣奥索拉-马尔皮基医院眼科进行了一项单中心回顾性研究,纳入了2022年至2024年间因MPK术后内皮功能衰竭接受nDSAEK治疗的患者。评估了术前和术后的最佳矫正视力(BCVA)、中央角膜厚度(CCT)和内皮细胞密度(ECD)。:纳入了18例患者的18只眼(平均年龄:39.94岁)。MPK的主要适应证为角膜炎症后白斑(77.7%)、外伤性瘢痕(16.7%)和圆锥角膜(5.6%)。术后一年,平均BCVA从1.40±0.42 logMAR显著提高到0.46±0.19 logMAR(<0.05),平均CCT从721±70.12 µm降至616±52.80 µm(<0.05)。术后平均ECD为1748±100个细胞/mm²,眼压低的患者需要再次注入空气泡。未报告免疫排斥反应或移植物失败。:nDSAEK是治疗MPK内皮功能衰竭的一种有前景的方法,具有良好的视觉和解剖学效果。